You can view the research column published every month by SMC Laboratories.
2025.02.02
It is now accepted that many factors are involved in exacerbating the NASH pathophysiology such as lipotoxicit…
2025.02.02
Today, we would like to give you a brief introduction to the choline-deficient, L-amino acid-defined, high-fat…
2025.02.02
Among our lineup is the STAM™ model, which is our proprietary model that shows a 100% progression rate from NA…
2025.02.02
In order to meet the diversifying needs of our clients, we often use our years of expertise conducting preclin…
2025.02.02
We would like to share with you about our Porcine pancreatic elastase (PPE)-induced pulmonary emphysema model…
2025.02.02
You may be aware of NAFLD (non-alcoholic fatty liver disease), but have you heard of MAFLD? Metabolic dysfunct…
2025.02.02
Between 9 – 12% of the worlds population suffers from Chronic Kidney Disease (CKD), but with no cure, ho…
2025.02.02
We would like to share with you our presentation from the 5th Korea Digestive Disease Week (KDDW 2021) (Novemb…
2025.02.02
We would like to introduce the combination study using NASH model mice. Combination study in NASH These…
2025.02.02
We would like to introduce our SSc-ILD model – an improvement on our existing systemic scleroderma model – whi…
We can help you advance your research.